On November 7, 2023, Tandem Diabetes Care, Inc. and David B. Berger, the Company?s Executive Vice President and Chief Operating Officer, determined that he will be stepping down from his current position effective December 31, 2023. Mr. Berger is responsible for the Company?s clinical, quality and regulatory functions, having served in a variety of leadership roles throughout his tenure at Tandem, including the historical oversight of legal, customer technical support and operations. Tandem anticipates that Mr. Berger will provide transition advisory services to the Company through 2024, and the Company will make a subsequent filing to disclose the terms of any related agreement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.93 USD | -0.97% | +0.99% | +48.51% |
May. 03 | Sector Update: Health Care Stocks Mixed in Afternoon Trading | MT |
May. 03 | Tandem Diabetes Care Shares Rise After Q1 Net Loss Shrinks, Sales Rise; Q2, 2024 Sales Guidance Set | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.51% | 2.84B | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.13% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+14.80% | 25.32B |
- Stock Market
- Equities
- TNDM Stock
- News Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. Announces Stepping Down of David B. Berger, Executive Vice President and Chief Operating Officer, Effective December 31, 2023